Biotech | April 06, 2022
Alvotech and STADA pave way to launching Hukyndra
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
The two-day event will showcase achievements and address issues pertaining to the industry
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
Subscribe To Our Newsletter & Stay Updated
